HKTDC’s New Executive Director Sophia Chong takes up post

On-Chain KYC(R) 2.0 Transforms Digital Identity with Privacy-Preserving Blockchain Attestations

Saudi Electricity Company Appoints Eng. Khalid Bin Salem AlGhamdi as Chief Executive Officer

Kincora Appoints Brent Cook and Laurie Thomas as Strategic Advisors and Derivative Exercise

Doubleview Gold Corp Announces Increased Footprint and Potential Volume at Its Hat Polymetallic Deposit in Northwestern British Columbia

TURBO set to accelerate growth following its first SET trading day

Taipei City Showcases AI Innovation and Smart City Leadership at Tech Week Singapore 2025

Internexa Launches PoP at HostDime’s Bogota, Colombia Data Center

Karbon-X Advances Alberta Solar Rewards Program to Expand Homeowner Access to Verified Carbon Credits

U.S. Polo Assn. Delivers Elevated Americana With the 2025 Fall-Winter Global Collection From Denver, Colorado

Star Plus Legend Partners with Shanghai Museum to Unveil ‘CHOUCHOU’ Themed Art Show

AEON Credit Reports 37.1% Increase in Net Profit for 1HFY2025/26

Golden Leaf International Group Limited Announces Listing Plan On GEM Of Hong Kong Stock Exchange

Bamboos Announces 2025 Annual Results

31 Concept Accelerates Next-Gen DPI Leadership With Strategic Acquisition of Xynthor AI

World’s First Methanol Dual-Fuel PCTC ‘CM HONG KONG’ makes its maiden voyage to Hong Kong

World Quantum Summit 2025 Concludes to a Full House: “Quantum Unboxed” Signals the Next Leap in AI and Industry Transformation

Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin